Flow Cytometry Market Expected to Reach $16.6 Billion by 2032

Flow cytometry market size was valued at $6.2 billion in 2022, and is estimated to reach $16.6 billion by 2032, growing at a CAGR of 10.3% from 2023 to 2032. Flow cytometry is a powerful analytical technique used in biology and medicine to characterize and quantify various properties of cells and particles in a fluid suspension. The key component of a flow cytometer is a flow cell, which houses the sample and directs it into the laser beam. As cells pass through the laser, they scatter light in multiple directions and emit fluorescent signals if labeled with specific fluorescent dyes or antibodies. These signals are then collected by detectors and converted into data, generating detailed information about cell size, shape, complexity, and the presence or absence of specific molecules on their surface.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Sysmex Corporation, BioMerieux SA, Agilent Technologies, Inc., Cytek Biosciences, Sartorius AG, Thermo Fisher Scientific Inc. , Miltenyi Biotec GmbH., Bio-Rad Laboratories, Inc. , Danaher Corporation, Becton, Dickinson and Company

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/90

On the basis of component, the flow cytometry industry is bifurcated into instruments, reagents and consumables, software and services. The reagents and consumables segment accounted for the highest market share in 2022, owing to high adoption of reagents in almost every procedure of flow cytometry.

On the basis of technology, the flow cytometry industry is segmented into cell-based flow cytomtry and bead-based flow cytometry. The cell-based flow cytometry segment was the highest revenue generating segment in 2022, owing to its wide scale application in the diagnosis of various diseases such as cancer and HIV, biomedical research, and its increasing use in monitoring the progress of drug treatment.

On the basis of application, academic & clinical applications segment accounted for the highest share of the flow cytometry market share in 2022, owing to increase in adoption of flow cytometer in the cell cycle analysis & cell proliferation. However, the diagnostic applications segment is expected to exhibit the fastest growth during the forecast period, owing to a rise in the use of technology in diagnostic applications.

On the basis of end user, the flow cytometry market analysis is segmented into hospitals, medical schools and clinical testing labs, commercial organizations, academic institutions and others. The commercial organizations segment accounted for a major share of the market share in the flow cytometry market in 2022, owing to heavy investments in R&D activities, advancements in cell- and bead-based technologies, growing patient population, and increasing demand for flow cytometry in drug discovery process.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/90

Asia-Pacific is expected to register the fastest growth during the flow cytometry market forecast. This is mainly attributed to major international companies outsourcing their research processes to contract research organizations (CROs) located in Asia-Pacific. Moreover, impending need for sophisticated healthcare facilities and rise in incidences of chronic diseases such as HIV and cancer are expected to boost the market growth.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.